Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Diagnostic Approach to High Proinsulin with Low Glucose and Normal Insulin/C-peptide

Pathophysiology and Diagnostic Significance

  • The persistence of inappropriately increased plasma insulin concentrations with low glucose concentration strongly suggests the presence of an islet cell tumor 1
  • An increase in the ratio of fasting proinsulin to insulin in an individual with hypoglycemia is particularly suggestive of an islet cell tumor 1
  • Normal C-peptide levels with elevated proinsulin may indicate a defect in the conversion of proinsulin to insulin, which can occur in certain islet cell tumors 2

Differential Diagnosis

  • Insulinomas are characterized by inappropriate insulin secretion with elevated proinsulin levels 3
  • Genetic abnormalities that result in the inability to convert proinsulin to insulin can be inherited in an autosomal dominant pattern 2
  • Mutations in proinsulin processing enzymes can lead to high proinsulin with normal insulin levels 2
  • Surreptitious insulin administration can be ruled out by measuring C-peptide, which would be low or suppressed with exogenous insulin administration 1, 4

Diagnostic Approach

  • The proinsulin-to-insulin ratio is typically elevated in insulinomas and can be used as a diagnostic tool 1
  • A 72-hour supervised fast with measurements of blood glucose, insulin, C-peptide, and proinsulin can help confirm hypoglycemia with inappropriate insulin/proinsulin secretion 3

Management Considerations

  • Surgical treatment is recommended for localized insulinomas, with a cure rate of approximately 90% 3
  • Preoperative stabilization of blood glucose through dietary measures and/or diazoxide may be necessary 3
  • Caution is advised when using somatostatin analogs due to potential worsening of hypoglycemia 3

Important Clinical Pearls

  • The absence of changes in glucose, insulin, and proinsulin concentrations in an individual with fasting hypoglycemia makes the diagnosis of an islet cell tumor unlikely 1
  • Measurement of C-peptide is essential in investigating nondiabetic hypoglycemia to rule out hypoglycemia due to surreptitious insulin administration 1, 4

REFERENCES

3

Diagnostic and Management of Hyperinsulinism [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

C-peptide Testing for Type 1 Diabetes Diagnosis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025